Investor Relations News: Breaking Investor Relations News, Comments and Articles. - Page: 4

United Spinal Co-Hosts 'From Within' Conference for Women Living with Physical Disabilities

NEW YORK, May 21, 2013 /PRNewswire-USNewswire/ -- United Spinal Association, Independence Care System (ICS), and the National MS Society are co-hosting the fourth annual 'From Within' Women's Health Conference to improve the lives, health, and well-being of women living with spinal cord injuries and disorders. (Logo: http://photos.prnewswire.com/prnh/20110413/MM82757LOGO) From Within atten...

Mindray Announces its Recent Filing of Annual Report on Form 20-F with the U.S. Securities and Exchange Commission

SHENZHEN, China, May 21, 2013 /PRNewswire/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today that on April 8, 2013, it filed with the Securities and Exchange Commission an Annual Report on Form 20-F that included audited financial statements for the year ended December 31, 2012. An electronic ve...

Echo Therapeutics Announces Institutional Review Board (IRB) Approval for Its Clinical Trial of the Symphony® CGM System

PHILADELPHIA, May 21, 2013 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE), a company developing its needle-free Symphony® CGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system, announced today that the Company's clinical trial of its Symphony CGM System has received Institutional Review Board (IRB) approval.  The IRB approval enables the co...

Largest-ever global survey of 1,273 women in 12 countries reveals women with advanced breast cancer feel left out of the breast cancer movement

Novartis International AG / Largest-ever global survey of 1,273 women in 12 countries reveals women with advanced breast cancer feel left out of the breast cancer movement . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the content of this announcement. Breast cancer is the most common cancer in women worldwide, yet survey confirms many women living with...

Synthetic Biologics to Present at the 2nd Annual Marcum LLP MicroCap Conference

ROCKVILLE, Md., May 21, 2013 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of biologics focused on the prevention and treatment of serious infectious diseases, announced today that Jeffrey Riley, CEO, will present at the 2nd Annual Marcum LLP MicroCap Conference on Thursday, May 30, 2013 in New York City at the Grand Hyatt Hotel. Mr. Riley is scheduled to prese...

4,994 Actions Currently Pending in DePuy Hip Implants Multidistrict Litigations: Now, AttorneyOne Can Provide Advice

According to court data updated on May 14, 2013, there are 4,994 actions currently pending in the DePuy ASR and DePuy Pinnacle Hip Implants Multidistrict Litigations. In light of this news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by DePuy Hip complications. San Diego,...

STAAR Surgical To Present At Upcoming Investor Conferences

MONROVIA, Calif., May 21, 2013 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it will participate in three upcoming investor conferences to review the Company's recent financial results and business developments with investors and interested parties. STAAR Surgical will present a...

Elbit Imaging Announces Receipt of Notices from Bank Leumi - Update

TEL AVIV, Israel, May 21, 2013 /PRNewswire/ -- Elbit Imaging Ltd. ("EI" or the "Company") (TASE, NASDAQ: EMITF) announced today, further to the Company's announcement dated March 20, 2013, that it has received a notice from Bank Leumi le-Israel B.M. (the "Bank"), which the Company vigorously reject, stating that the Bank plans to exercise its rights to withdraw the securities deposited by the Com...

2013 FDA Drug Approval Calendar

BOSTON (TheStreet) -- Gilead Sciences and Amarin highlight the updated list of biotech and pharmaceutical companies with FDA drug approval decisions expected for the remainder of 2013. The next era of hepatitis C therapy could begin on Dec. 6, if FDA approves Gilead's sofosbuvir. Amarin is hoping FDA approves an expanded label for its prescription-grade fish oil pill Vascepa on Dec. 20. Sarept...

Research-based Pharmaceutical Industry Launches 'Do You Mind?' Campaign to Fight Mental and Neurological Disorders

GENEVA, May 21, 2013 /PRNewswire/ --   Campaign launched during World Health Assembly, where world's health ministers gather to address the large physical and economic costs of these disorders Mental and neurological disorders (MNDs) affect 700 million people annually and account for 30 percent of global non-communicable disease (NCD) burden 'Do You Mind?' helps patients, family members,...

Phosphagenics Signs Research Agreement with the Agricultural Research Service

MELBOURNE, Australia, May 20, 2013 /PRNewswire/ -- Collaboration with the U.S. Department of Agriculture's (USDA) Agricultural Research Service (ARS) in treatment of mastitis Major global market opportunity Trials to begin in the second half 2013 Australian drug delivery technology company Phosphagenics Limited (ASX: POH, OTCQX: PPGNY) will collaborate with the U.S. Department of Agr...

Martin Midstream Partners L.P. to Present at the 2013 NAPTP Investor Conference

KILGORE, Texas, May 21, 2013 (GLOBE NEWSWIRE) -- Martin Midstream Partners L.P. (Nasdaq:MMLP) ("MMLP" or the "Partnership") announced today that Robert D. Bondurant, Executive Vice President and Chief Financial Officer of Martin Midstream GP LLC, MMLP's general partner, and other members of senior management, will present at the 2013 Master Limited Partnership Investor Conference sponsored by the...

Eagle Rock Energy Partners, L.P. to Present at the 2013 NAPTP MLP Investor Conference in Stamford, CT

HOUSTON, May 21, 2013 (GLOBE NEWSWIRE) -- Eagle Rock Energy Partners, L.P. (Nasdaq:EROC) (the "Partnership") announced today that Joseph A. Mills, Chief Executive Officer, and Jeffrey P. Wood, Chief Financial Officer, will be presenting at the 2013 National Association of Publicly Traded Partnerships' MLP Investor Conference in Stamford, CT on Wednesday, May 22nd at 11:45am Eastern Time. Mr. Mill...

GeneNews to Present at the Bloom Burton & Co. Healthcare Investor Conference

TORONTO, May 21, 2013 (GLOBE NEWSWIRE) -- GeneNews Limited (TSX:GEN) ("GeneNews") announced today that its President and Chief Operating Officer, Gailina J. Liew, will present an update on the Company's business at the 2nd Annual Bloom Burton & Co. Healthcare Investor Conference on Wednesday, May 22, 2013 at 2:30 PM ET. The conference will be held at the Toronto Board of Trade in Toronto, ON....

Legacy Reserves LP to Present at NAPTP 2013 MLP Investor Conference

MIDLAND, Texas, May 21, 2013 (GLOBE NEWSWIRE) -- Legacy Reserves LP ("Legacy") (Nasdaq:LGCY) today announced that Dan Westcott, Executive Vice President and Chief Financial Officer, and Paul Horne, Executive Vice President and Chief Operating Officer, will present at the National Association of Publicly Traded Partnerships' ("NAPTP") 2013 MLP Investor Conference in Stamford, Connecticut, on Wedne...

Revolutions Medical Receives Contract for 12 Million RevVac(TM) Safety Syringes From Its Brazilian Distributor

CHARLESTON, SC--(Marketwired - May 21, 2013) - Revolutions Medical Corporation ("Revolutions Medical" or the "Company") (OTCQB: RMCP) has received a 12 million unit contract of its RevVac™ auto-retractable vacuum safety syringe from AGN Tech International, LLC, ("AGN Tech") the exclusive distributor of all RevVac™ safety syringe product lines in Brazil. The contract is for 1 million units pe...

Rosetta Resources Inc. to Present at Upcoming Investor Conferences

HOUSTON, May 21, 2013 (GLOBE NEWSWIRE) -- Rosetta Resources Inc. (Nasdaq:ROSE) ("Rosetta" or the "Company") today announced its participation in two upcoming investor conferences. Larry Jernigan, Vice President, Resource Management, will present on the Eagle Ford Panel at the SunTrust Robinson Humphrey 2013 "Play-by-Play" Oil & Gas Conference on Wednesday, May 29, 2013, at 2:05 p.m. Eastern T...

Information Professionals to Highlight the Role of the Solo Practitioner in the Expanding Information Universe

Members of the Association of Independent Information Professionals who exemplify the “Right Stuff” skills and attitudes of the solo info pro will share the secrets of their success at the Special Libraries Association 2013 Annual Conference in San Diego, California. Baton Rouge, LA (PRWEB) May 20, 2013 At a time when libraries and research centers are being stretched thin, downsized, or elim...

Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego

Workshop Style Conference to Take a Deep Dive into the Elements of a Successful Digital Health Venture, Providing the Skills, Tools and Resources Businesses Need to Thrive in the Digital Health Space San Diego, CA (PRWEB) May 20, 2013 This summer, digital health leaders from across the country and around the world will make the pilgrimage to San Diego, CA, the emerging digital health mecca, for t...

Karyopharm raises $48.2 million in series B

Cancer company Karyopharm Therapeutics Inc. (Natick, Mass.) raised $48.2 million in a series B round led by an undisclosed private investor. New investor Delphi Ventures and additional undisclosed investors participated. Delphi Ventures' Deepa Pakian...

Valeant Pharmaceuticals To Present At 34th Annual Goldman Sachs Global Healthcare Conference

LAVAL, Quebec, May 20, 2013 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced members of its senior management team will make a presentation at the 34th Annual Goldman Sachs Healthcare Conference on Tuesday, June 11, 2013 at 9:20 a.m. PT. The conference will be held at the Terranea Resort in Los Angeles, CA. A live webcast and audio ar...

Royalty beißt sich bei Elan fest: Übernahmeangebot auf 12,50 Dollar erhöht

Der Investor Royalty Pharma lässt sich von Elan nicht abschütteln: Die Amerikaner erhöhten ihr Übernahmeangebot für das irische Biotechunternehmen trotz dessen erbitterten Widerstands auf 12,50 US...

Medtronic to Honor Those Who Give Back After Receiving Life-Enhancing Medical Technology

(View the Bakken Invitation video here) Live On. Give On:  Ten inspirational people will be awarded a $20,000 charitable donation and be honored at an awards celebration in Hawaii as part of the first annual Bakken Invitation MINNEAPOLIS - May 20, 2013- Medtronic, Inc. (NYSE: MDT) announced today that applications are being accepted for the inaugural Bakken Invitation, a global program desig...

Royalty Pharma ups offer for Elan to $12.50/shr

LONDON, May 20 (Reuters) - U.S. investor Royalty Pharma raised its offer to $12.50 per share for Irish drugmaker Elan on Monday, representing a premium of 45 percent to Elan's enterprise value, it said.

Uroplasty To Announce Fiscal Fourth Quarter And Full Year 2013 Financial Results On May 30, 2013

MINNEAPOLIS, May 20, 2013 /PRNewswire/ -- Uroplasty, Inc. (Nasdaq: UPI) announced today that it will release financial results for the fiscal fourth quarter and full year ended March 31, 2013 at the market close on Thursday, May 30, 2013. The Company will host a conference call and webcast to discuss these results on Thursday, May 30, 2013 at 4:30 p.m. Eastern Time (3:30 p.m. Cent...